Fig. 3
From: Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
The target protein of kayadiol in NKTCL cells. YT cells were treated with kayadiol (12.5 μM) for 24 h. A Proteome profiling of signaling pathways showed p53 activation by kayadiol treatment in YT cells. B The expression of phosphorylated-p53, p53, SLC7A11, and GPX4 were examined by Western blotting, β-actin served as an endogenous control for normalization. C Quantification of the western blot signals was presented as means ± SD from 3 independent experiments, *P < 0.05 vs control group